204 related articles for article (PubMed ID: 35221589)
21. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis.
Hagforsen E; Edvinsson M; Nordlind K; Michaëlsson G
Br J Dermatol; 2002 Mar; 146(3):383-91. PubMed ID: 11952537
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
[TBL] [Abstract][Full Text] [Related]
23. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
Yamamoto T
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1227-32. PubMed ID: 19453807
[TBL] [Abstract][Full Text] [Related]
24. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States.
Hanna ML; Singer D; Valdecantos WC
Curr Med Res Opin; 2021 May; 37(5):735-742. PubMed ID: 33622113
[TBL] [Abstract][Full Text] [Related]
25. Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab.
Herrero-Moyano M; Capusan TM; Martínez-Mera C; Llamas-Velasco M; Daudén E
JAAD Case Rep; 2018 Sep; 4(8):842-844. PubMed ID: 30246137
[No Abstract] [Full Text] [Related]
26. Palmoplantar pustulosis with psoriatic arthritis ineffective to interleukin-17 inhibitors: two patients successfully treated with upadacitinib.
Zhang ZY; Mi WY; Wang YY; Li W
J Dermatolog Treat; 2023 Dec; 34(1):2280508. PubMed ID: 37968926
[TBL] [Abstract][Full Text] [Related]
27. Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?
Lesiak A; Bednarski I; Pałczyńska M; Kumiszcza E; Kraska-Gacka M; Woźniacka A; Narbutt J
Postepy Dermatol Alergol; 2016 Oct; 33(5):336-339. PubMed ID: 27881938
[TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study.
Gisondi P; Bellinato F; Girolomoni G
Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893820
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases.
Pinter A; Wilsmann-Theis D; Peitsch WK; Mössner R
J Dermatol; 2019 May; 46(5):426-430. PubMed ID: 30786053
[TBL] [Abstract][Full Text] [Related]
30. Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study.
Mrowietz U; Burden AD; Pinter A; Reich K; Schäkel K; Baum P; Datsenko Y; Deng H; Padula SJ; Thoma C; Bissonnette R
Dermatol Ther (Heidelb); 2021 Apr; 11(2):571-585. PubMed ID: 33661508
[TBL] [Abstract][Full Text] [Related]
31. Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis.
Yamamoto T
Adv Otorhinolaryngol; 2011; 72():89-92. PubMed ID: 21865699
[TBL] [Abstract][Full Text] [Related]
32. TLN-58, an Additional hCAP18 Processing Form, Found in the Lesion Vesicle of Palmoplantar Pustulosis in the Skin.
Murakami M; Kameda K; Tsumoto H; Tsuda T; Masuda K; Utsunomiya R; Mori H; Miura Y; Sayama K
J Invest Dermatol; 2017 Feb; 137(2):322-331. PubMed ID: 27771329
[TBL] [Abstract][Full Text] [Related]
33. Dietary habits in Japanese patients with palmoplantar pustulosis.
Serizawa N; Okazaki S; Otsuka Y; Koto M; Okabe K; Ito M; Morita T; Hoashi T; Saeki H; Abe N; Mori M; Okubo Y; Yano Y; Mitsui H; Kanda N
J Dermatol; 2021 Mar; 48(3):366-375. PubMed ID: 33404125
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations.
Freitas E; Rodrigues MA; Torres T
Clin Cosmet Investig Dermatol; 2020; 13():561-578. PubMed ID: 32884319
[TBL] [Abstract][Full Text] [Related]
35. Acrosyringium is the main site of the vesicle/pustule formation in palmoplantar pustulosis.
Murakami M; Ohtake T; Horibe Y; Ishida-Yamamoto A; Morhenn VB; Gallo RL; Iizuka H
J Invest Dermatol; 2010 Aug; 130(8):2010-6. PubMed ID: 20393482
[TBL] [Abstract][Full Text] [Related]
36. Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients.
Xiaoling Y; Dan S; Hongzhong J
An Bras Dermatol; 2019; 94(6):658-663. PubMed ID: 31789248
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis.
Wang CQ; Haxhinasto S; Garcet S; Kunjravia N; Cueto I; Gonzalez J; Rambhia D; Harari O; Sleeman MA; Hamilton JD; Lim WK; Freudenberg J; Kalliolias GD; Thakker P; Bissonnette R; Krueger JG
J Invest Dermatol; 2023 Jan; 143(1):87-97.e14. PubMed ID: 35934055
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
[TBL] [Abstract][Full Text] [Related]
39. [Palmoplantar pustulosis].
Berbis P
Rev Prat; 1991 Oct; 41(22):2165-8. PubMed ID: 1784916
[TBL] [Abstract][Full Text] [Related]
40. Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.
Assan F; Husson B; Hegazy S; Seneschal J; Aubin F; Mahé E; Jullien D; Sbidian E; D'Incan M; Conrad C; Brenaut E; Girard C; Richard MA; Bachelez H; Viguier M;
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1578-1583. PubMed ID: 35366356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
